Jeffrey A. Wesson

2.8k total citations
37 papers, 2.3k citations indexed

About

Jeffrey A. Wesson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Biomaterials. According to data from OpenAlex, Jeffrey A. Wesson has authored 37 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 8 papers in Biomaterials. Recurrent topics in Jeffrey A. Wesson's work include Kidney Stones and Urolithiasis Treatments (32 papers), Porphyrin Metabolism and Disorders (9 papers) and Calcium Carbonate Crystallization and Inhibition (8 papers). Jeffrey A. Wesson is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (32 papers), Porphyrin Metabolism and Disorders (9 papers) and Calcium Carbonate Crystallization and Inhibition (8 papers). Jeffrey A. Wesson collaborates with scholars based in United States, United Kingdom and India. Jeffrey A. Wesson's co-authors include Michael D. Ward, Jack G. Kleinman, Xiaoxia Sheng, Jeremy Hughes, Richard J. Johnson, Elaine M. Worcester, Taesung Jung, Jeffrey D. Rimer, Tiina Kipari and Vuddhidej Ophascharoensuk and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Jeffrey A. Wesson

37 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey A. Wesson United States	22	1.2k	554	519	474	375	37	2.3k
Rosemary L. Ryall Australia	34	1.7k 1.5×	602 1.1×	402 0.8×	421 0.9×	446 1.2×	111	3.6k
Neil S. Mandel United States	32	1.4k 1.2×	721 1.3×	177 0.3×	423 0.9×	201 0.5×	83	3.1k
John L. Meyer United States	30	509 0.4×	329 0.6×	499 1.0×	283 0.6×	328 0.9×	83	2.7k
Jack G. Kleinman United States	28	1.1k 1.0×	697 1.3×	152 0.3×	360 0.8×	80 0.2×	68	2.2k
Phulwinder K. Grover Australia	23	841 0.7×	426 0.8×	130 0.3×	167 0.4×	111 0.3×	59	1.6k
William Robertson United Kingdom	39	3.6k 3.1×	785 1.4×	231 0.4×	351 0.7×	202 0.5×	129	5.5k
P. G. Werness United States	16	590 0.5×	368 0.7×	133 0.3×	282 0.6×	67 0.2×	22	1.4k
Dirk J. Kok Netherlands	21	680 0.6×	243 0.4×	84 0.2×	175 0.4×	159 0.4×	63	1.4k
Jian‐Ming Ouyang China	26	762 0.6×	358 0.6×	448 0.9×	32 0.1×	297 0.8×	216	2.3k
Sanford R. Simon United States	31	500 0.4×	1.2k 2.2×	123 0.2×	157 0.3×	182 0.5×	115	3.7k

Countries citing papers authored by Jeffrey A. Wesson

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Wesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Wesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Wesson more than expected).

Fields of papers citing papers by Jeffrey A. Wesson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Wesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Wesson. The network helps show where Jeffrey A. Wesson may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Wesson

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Wesson. A scholar is included among the top collaborators of Jeffrey A. Wesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Wesson. Jeffrey A. Wesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wesson, Jeffrey A., et al.. (2024). Comparison of cat stone matrix and cat urine proteomes to human calcium oxalate stone matrix and urine proteomes. Urolithiasis. 52(1). 130–130. 1 indexed citations

2.

Wesson, Jeffrey A., et al.. (2022). Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes. Urolithiasis. 50(6). 653–664. 3 indexed citations

3.

Tian, Yu, et al.. (2021). Protein primary structure correlates with calcium oxalate stone matrix preference. PLoS ONE. 16(9). e0257515–e0257515. 14 indexed citations

4.

Wesson, Jeffrey A., et al.. (2019). Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?. Urolithiasis. 47(6). 521–532. 27 indexed citations

5.

Mandel, Neil S., et al.. (2017). Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal. Urolithiasis. 45(4). 337–346. 21 indexed citations

6.

Rimer, Jeffrey D., et al.. (2016). The role of macromolecules in the formation of kidney stones. Urolithiasis. 45(1). 57–74. 68 indexed citations

7.

Mandel, Neil S., et al.. (2015). Polyisobutylene Urolithiasis Due to Ileal Conduit Urostomy Appliance: An Index Case. Journal of Endourology Case Reports. 1(1). 41–43. 1 indexed citations

8.

Kleinman, Jack G., et al.. (2015). Exploring calcium oxalate crystallization: a constant composition approach. Urolithiasis. 43(5). 397–409. 17 indexed citations

9.

Halligan, Brian, et al.. (2012). Relative deficiency of acidic isoforms of osteopontin from stone former urine. Urological Research. 40(5). 447–454. 17 indexed citations

10.

Viswanathan, Pragasam, et al.. (2011). Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein. Urological Research. 39(4). 269–282. 56 indexed citations

11.

Rimer, Jeffrey D., Zhihua An, Michael H. Lee, et al.. (2010). Crystal Growth Inhibitors for the Prevention of l -Cystine Kidney Stones Through Molecular Design. Science. 330(6002). 337–341. 203 indexed citations

12.

Kleinman, Jack G., Елена А. Сорокина, & Jeffrey A. Wesson. (2010). Induction of apoptosis with cisplatin enhances calcium oxalate crystal adherence to inner medullary collecting duct cells. Urological Research. 38(2). 97–104. 8 indexed citations

13.

Kleinman, Jack G., et al.. (2008). Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition. Kidney International. 74(7). 919–924. 20 indexed citations

14.

Wesson, Jeffrey A. & Michael D. Ward. (2006). Role of crystal surface adhesion in kidney stone disease. Current Opinion in Nephrology & Hypertension. 15(4). 386–393. 42 indexed citations

15.

Sheng, Xiaoxia, Michael D. Ward, & Jeffrey A. Wesson. (2005). Crystal Surface Adhesion Explains the Pathological Activity of Calcium Oxalate Hydrates in Kidney Stone Formation. Journal of the American Society of Nephrology. 16(7). 1904–1908. 107 indexed citations

16.

Wesson, Jeffrey A., et al.. (2005). Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Urological Research. 33(3). 206–212. 48 indexed citations

17.

Сорокина, Елена А., Jeffrey A. Wesson, & Jack G. Kleinman. (2004). An Acidic Peptide Sequence of Nucleolin-Related Protein Can Mediate the Attachment of Calcium Oxalate to Renal Tubule Cells. Journal of the American Society of Nephrology. 15(8). 2057–2065. 34 indexed citations

18.

Kipari, Tiina, et al.. (2002). Osteopontin—a molecule for all seasons. QJM. 95(1). 3–13. 313 indexed citations

19.

Wesson, Jeffrey A., Elaine M. Worcester, John H. Wiessner, Neil S. Mandel, & Jack G. Kleinman. (1998). Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney International. 53(4). 952–957. 10 indexed citations

20.

Wesson, Jeffrey A., Elaine M. Worcester, John H. Wiessner, Neil S. Mandel, & Jack G. Kleinman. (1998). Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney International. 53(4). 952–957. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact